Drug Patents owned by Zyla

1. Drug name - ARYMO ER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9549899 ZYLA Abuse deterrent pharmaceutical compositions for controlled release Jul, 2033

(10 years from now)

US9044402 ZYLA Abuse-deterrent pharmaceutical compositions for controlled release Jul, 2033

(10 years from now)

Drugs and Companies using MORPHINE SULFATE ingredient

Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET, EXTENDED RELEASE;ORAL Discontinued
30MG TABLET, EXTENDED RELEASE;ORAL Discontinued
60MG TABLET, EXTENDED RELEASE;ORAL Discontinued

2. Drug name - OXAYDO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7981439 ZYLA Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof Nov, 2023

(1 year, 1 month from now)

US7510726 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms Nov, 2023

(1 year, 1 month from now)

US8409616 ZYLA Extended release opioid abuse deterrent compositions and methods of making same Nov, 2023

(1 year, 1 month from now)

US8637540 ZYLA Compositions for deterring abuse of opioid containing dosage forms Nov, 2023

(1 year, 1 month from now)

US9492443 ZYLA Abuse deterrent compositions and methods of making same May, 2024

(1 year, 7 months from now)

US7201920 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms Mar, 2025

(2 years from now)

More Information on Dosage
Strength Dosage Availability
5MG TABLET;ORAL Prescription
7.5MG TABLET;ORAL Prescription

3. Drug name - VIVLODEX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9526734 ZYLA Formulation of meloxicam Mar, 2033

(10 years from now)

US9649318 ZYLA Formulation of meloxicam Mar, 2035

(12 years from now)

US9808468 ZYLA Formulation of meloxicam Mar, 2035

(12 years from now)

Drugs and Companies using MELOXICAM ingredient

Treatment: Management of osteoarthritis pain by administering 10 mg of meloxicam; management of osteoarthritis pain by administering 5 mg of meloxicam

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
5MG CAPSULE;ORAL Discontinued
10MG CAPSULE;ORAL Discontinued

4. Drug name - ZORVOLEX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8999387 ZYLA Formulation of diclofenac Apr, 2030

(7 years from now)

US9180095 ZYLA Formulation of diclofenac Apr, 2030

(7 years from now)

US8679544 ZYLA Formulation of diclofenac Apr, 2030

(7 years from now)

US9017721 ZYLA Formulation of diclofenac Apr, 2030

(7 years from now)

US9180096 ZYLA Formulation of diclofenac Apr, 2030

(7 years from now)

US9173854 ZYLA Formulation of diclofenac Apr, 2030

(7 years from now)

US9186328 ZYLA Formulation of diclofenac Apr, 2030

(7 years from now)

Drugs and Companies using DICLOFENAC ingredient

Treatment: Treatment of pain

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
18MG CAPSULE;ORAL Discontinued
35MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.